检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:丁兆红[1] 刘青[1] 王代宪[1] 迟玉春[1] 侯树爱[1]
机构地区:[1]日照市人民医院重症医学科,山东省日照276800
出 处:《中国基层医药》2010年第17期2358-2360,共3页Chinese Journal of Primary Medicine and Pharmacy
摘 要:目的探讨自制匀浆膳在合并糖尿病的危重症患者营养支持治疗中的应用效果和安全性。方法74例合并糖尿病的危重症患者按入院单双号随机分为两组(观察组37例和对照组37例),两组在原发病治疗的基础上,按照额定热量,观察组给予自制匀浆膳进行营养支持治疗;对照组给予肠内营养乳剂(TP)进行营养支持治疗,治疗4周。比较两组糖代谢情况、各项营养指标及胃肠功能障碍指标等差异。结果与治疗前相比,两组患者空腹血糖、果糖胺水平显著下降(均P〈0.05),而各营养指标显著升高,但两组间治疗后空腹血糖、餐后2h血糖、果糖胺水平各营养指标及低血糖、胃肠道并发症发生率差异均无统计学意义(均P〉0.05)。结论合并糖尿病ICU危重症患者应用自制匀浆膳配合治疗,与肠内营养乳剂疗效相当,但价格便宜,经济实用,不失为一种好的肠内营养支持方法。Objective To investigate the effect and safety of self-made blenderized diet used for nutritional support treatment in the ICU critically ill patients with diabetes. Methods 74 ICU critically ill patients with diabetes were randomly divided into two groups:study group and control group. The self-made blenderized diet were given to the patients in study group and enteral nutrition to the patients in control group for nutritional support treatment for four weeks. Then glucose metabolism, various nutrition indicators and gastrointestinal dysfunction were observed in these two groups. Results The fasting blood glucose and fructosamine levels were decreased significantly, while the nutritional indicators was significantly higher after treatment than at baseline in all patients. There was no significant difference in the levels of fasting blood glucose, postprandial glucose, fructosamine and nutritional indicators between two groups after treatment, so were the incidence of the hypoglycemia and gastrointestinal complications. Conclusion The self-made blenderized diet was a good enteral nutrition support therapy for ICU critically ill patients with diabetes which had a considerable effect,but more cheaper,and practical compared to the enteral nutrition emulsions.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117